Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1
about
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionImmune modulation during latent herpesvirus infectionHuman herpesvirus 6Analysis of fumonisin B1-induced apoptosisThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureTransgenic cell lines for detection of animal virusesGenital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein.Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancerFunctional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein.Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0.Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferonThe cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania.Cellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- virusesCytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group.Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression.Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cellsCooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery.Gene expression during reactivation of herpes simplex virus type 1 from latency in the peripheral nervous system is different from that during lytic infection of tissue culturesSp1 binding plays a critical role in Erb-B2- and v-ras-mediated downregulation of alpha2-integrin expression in human mammary epithelial cells.Replication-incompetent herpesvirus vector delivery of an interferon alpha gene inhibits human immunodeficiency virus replication in human monocytes.The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virusThe presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27.Role of tumor necrosis factor alpha in activation and replication of the tat-defective human immunodeficiency virus type 1.Differential contribution of herpes simplex virus type 1 gene products and cellular factors to the activation of human immunodeficiency virus type 1 provirus.The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus.The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency.
P2860
Q24550678-F23F524D-B156-4857-9F65-ECD01B43D7EFQ24624044-11AAE80E-5166-4362-92FF-7A84E8B1C420Q24683663-009FFC70-6982-4410-B1B8-3E7F098CA95BQ24815299-80373C00-4CDD-4C3B-9A37-2804FF44DD8FQ26864344-E39E511E-0E66-4676-B9C7-8A68B634976DQ27477859-59732934-3A2F-4A1E-9C0E-7ADCD39E1E5AQ33336603-8D673560-1345-4925-BD19-BCCB2F969F2CQ33580416-5C292791-F816-4A24-A9EF-80D2C61A26E7Q33581303-6A52A762-112C-4575-BB0F-7BE809B62D9BQ33649357-552E1144-A05B-4517-868B-8F6A8F194E7DQ33666097-6E2B1DF6-E5B0-47B4-A6D0-B40F2021D6D0Q33819612-BF9708DE-2BAA-41F3-9795-8A6531EFB668Q33919346-6BFAA9B9-9BB9-4778-9250-4342DDDF7CC1Q33930958-3F111778-3DA6-4DA0-B20D-0296B251A305Q34168234-F091E3E7-2B55-4F06-AECB-FF3EC40C875EQ34285905-05160515-14E1-435D-9EF4-DAAAE47A1D98Q34330457-17273001-CA63-449D-B631-7153C893A272Q34630266-6DAF6711-1DA2-4767-8325-82A438DFCBB7Q34647412-9BA2BFAA-591F-4189-B727-5931B468C4EFQ34792820-9E1B9C19-5FA3-4532-A8D7-E37E758AD2A2Q34998851-27871DAB-5F44-4FBB-94E1-BF84D51FC1E5Q35076929-055D5DB1-FA3F-4B90-A3CC-F4CB814808ACQ35585672-445D32EF-6FE8-4180-A545-D3E5A6A128A0Q35608425-6FB0E380-9021-40A7-80F5-582FA8C4D7B5Q35828561-7669121E-CAF2-4FE5-97A3-C65751411823Q35828854-1A0DCF7C-B27E-491C-8A4F-7189CE754392Q35870516-706202F0-FDC7-4D81-AB16-222B16A8F395Q35876353-7E6AE881-4084-4E0E-BEA3-357A5E2FEBF4Q35888200-5911D3BA-118A-4716-8268-D9ECD0DBEC2FQ36563516-98FEBB3F-8FBA-481C-87F7-12DADF492738Q36574880-3596DF3E-B983-43AC-B554-03022D9BB7FFQ36626966-5DEF5826-8D04-469C-9D12-059139F3DDF4Q36628240-363BDD6A-FADC-4842-819F-00D286DDDDA6Q36631542-E7968D42-D9FE-4546-A94A-53934AC787D9Q36632309-3E22F55C-C2A2-4717-8845-1FDE947139EBQ36642257-179D81A6-2784-407D-AF77-721E89F9D819Q36650675-36CEECDB-C0C5-4821-A357-C12F758A1A76Q36653717-F6F3837B-3796-4451-AC8C-0B5F4A81BF11Q36653844-7755607B-9682-4E3D-8503-9C5C33EA93BDQ36655446-8063D9AD-9AD3-4A6E-B053-AB26668E2319
P2860
Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1
description
1987 nî lūn-bûn
@nan
1987 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Activation of human immunodefi ...... oded by herpes simplex virus 1
@ast
Activation of human immunodefi ...... oded by herpes simplex virus 1
@en
Activation of human immunodefi ...... oded by herpes simplex virus 1
@nl
type
label
Activation of human immunodefi ...... oded by herpes simplex virus 1
@ast
Activation of human immunodefi ...... oded by herpes simplex virus 1
@en
Activation of human immunodefi ...... oded by herpes simplex virus 1
@nl
prefLabel
Activation of human immunodefi ...... oded by herpes simplex virus 1
@ast
Activation of human immunodefi ...... oded by herpes simplex virus 1
@en
Activation of human immunodefi ...... oded by herpes simplex virus 1
@nl
P2093
P2860
P356
P1476
Activation of human immunodefi ...... oded by herpes simplex virus 1
@en
P2093
D P Bednarik
G S Hayward
J G Sodroski
P2860
P304
P356
10.1073/PNAS.84.21.7408
P407
P577
1987-11-01T00:00:00Z